Rhode Island biologics regulations.

Who may administer PRP, exosomes and stem cells in Rhode Island, and which agencies to check.

A physician at a desk reading regulatory documents

Who may administer biologics in Rhode Island?

In Rhode Island, only licensed physicians can administer stem cell therapies.

Official sources

Rhode Island compliance guide.

FDA Compliance

The U.S. Food and Drug Administration (FDA) regulates human cells, tissues, and cellular and tissue-based products (HCT/P). Clinics must comply with FDA guidelines for HCT/P to ensure safety and efficacy. This includes adherence to Current Good Tissue Practice (CGTP) and registration requirements outlined under 21 CFR Part 1271.

Rhode Island State Regulations

Clinics must also follow state-specific regulations. Refer to the Rhode Island Department of Health for detailed compliance rules regarding biologics. State policies may include licensing standards and additional safety protocols.

Provider Qualifications

In Rhode Island, only licensed physicians can administer stem cell therapies. Providers should verify their eligibility through the Rhode Island Board of Medical Licensure. Qualifications may involve specialized training in regenerative medicine.

Patient Informed Consent

Clinics are required to obtain comprehensive informed consent. This process must cover:

  • Explanation of the treatment's experimental status
  • Potential risks and benefits
  • Alternative options and patient rights. Ensuring transparent communication helps protect both the clinic and the patient legally.

Additional Sections

Pre-Treatment and Post-Treatment Protocols

Develop thorough pre-treatment screening and post-treatment follow-up procedures to ensure patient safety and compliance.

Standard Operating Procedures (SOPs)

Maintain up-to-date SOPs addressing the handling, storage, and administration of biologic products.

Medical Liability Insurance

Ensure that your clinic holds comprehensive liability coverage tailored to regenerative medicine.

Marketing Compliance

All promotional materials must be truthful and comply with FDA advertising regulations to avoid misleading claims. Review FDA marketing guidelines for further details.

This guide is a general summary to help clinics understand compliance requirements for biologics in Rhode Island. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.

Rhode Island: common questions.

Who can administer stem cells, PRP and exosomes in Rhode Island?
In Rhode Island, only licensed physicians can administer stem cell therapies. This is a general summary, not legal advice. Confirm with the state board.
Are stem cell and exosome therapies FDA-approved in Rhode Island?
FDA rules are federal, so they apply in Rhode Island as everywhere else. Exosome and stem cell therapies are not FDA-approved for therapeutic use, and PRP applications are considered off-label.
Do I need an IRB-approved study to offer biologics in Rhode Island?
Investigational treatment belongs inside a reviewed study with proper informed consent. IRB review is not FDA authorisation: culture-expanded and other more-than-minimally-manipulated cell products generally need an IND before use in people.
How do I start offering biologics in Rhode Island?
Start with the live webinar, then a discovery call and live training. After that we verify your Rhode Island licence, protocol, product sourcing, consent process and advertising before you are listed for patient inquiries.

Practising in Rhode Island? Start with the webinar.

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.